ArticlePloS one2013

Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.

Karolin H Nord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.